Meta Pixel

News and Announcements

Dovetail Signs Experienced Childcare Operating Group After Attracting National Interest

  • Published January 29, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Dovetail’s Aspendale Childcare project has made significant progress, obtaining an executed Head of Agreement with an experienced childcare operating group at the beginning of the year. This agreement is an important milestone for the project as it signifies the commercial viability of the childcare centre being developed. It’s also a particularly notable vote of confidence given the proven track-record of the established childcare operating group involved.

Further progress has been achieved as demolition works have also commenced on-site in preparation for construction works to begin in March 2020.

The journey from concept design to solid built form is well underway for Dovetail’s Aspendale Childcare project. However, it’s not too late to be a part of this promising venture! Double digit investment opportunities are still available for a limited time before construction commences. Visit Dovetail’s Childcare Development deal room in the link below to view the Information Memorandum or call Cherie on 03 9583 3486 for further details.

Visit Childcare Centre Deal Room

Photo Caption:  Demolition works begin on-site for Dovetail Development’s Aspendale Childcare project.

About Dovetail Developments

Dovetail Developments is a multi-awarded property development company located in Melbourne’s South East specialising in developing architecturally inspired multi-unit townhouse projects and childcare centres. Dovetail provides a holistic end-to-end service offering, encompassing property research, acquisition, design, sales & marketing, finance and project management.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now